RxDoctor Payments Data

Mallory Eubank

Family · Lees Summit, MONPI 1407410210

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 206 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by AstraZeneca at 34.3% of the total. Reporting peaked in 2021 at $1,637 and has fallen 89.6% since, to $170 in 2024.

$3,670in general payments, 2019–2025

Across 206 payments — averaging $17.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$1K
  • Boehringer Ingelheim$740
  • Grifols USA, LLC$325
  • GSK$298
  • Sanofi$282
  • Mylan Specialty L.p.$248
  • plus $516 from 7 others

What the payments were for

  • Food & beverage$3,670100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,670 in reported general payments places this provider in the 85th percentile of 3,812 family providers in Missouri.

See all family providers in Missouri →

Other family in Lees Summit

See the full list for Missouri →

Where these figures come from

Is this you, or does something look wrong? →